Effect of energy deficiency on estrogen metabolism in premenopausal women

Medicine and Science in Sports and Exercise

Volumn 39, Issue 7, 2007, Pages 1090-1097

  Westerlind, Kim C ^a   Williams, Nancy I ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Calorie restriction; Estradiol; Exercise

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTRADIOL; ESTROGEN; FAT;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY FAT; BODY MASS; BREAST CANCER; CALORIC RESTRICTION; CANCER RISK; CONTROLLED STUDY; DIET; ESTROGEN METABOLISM; EXERCISE; FEMALE; FITNESS; FOLLICULAR PHASE; HIGH RISK PATIENT; HUMAN; HUMAN EXPERIMENT; LIFESTYLE MODIFICATION; LUTEAL PHASE; MENSTRUATION; METABOLITE; NORMAL HUMAN; PREMENOPAUSE; RISK REDUCTION; SITTING; URINALYSIS; URINE LEVEL; WEIGHT REDUCTION;

ADULT; BREAST NEOPLASMS; ENERGY METABOLISM; ESTROGENS; EXERCISE; FEMALE; HUMANS; PENNSYLVANIA; PREMENOPAUSE; PROSPECTIVE STUDIES;

EID: 34347349138     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1097/mss.0b013e3180485727     Document Type: Article

References (41)

1. ATKINSON, C., J. W. LAMPE, S. S. TWOROGER, et al. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 13:868-874, 2004.
2. BECK, A. T., C. H. WARD, M. MENDELSON, J. MOCK, and J. ERBAUGH. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
3. BELL, M. C., P. CROWLEY-NOWICK, H. L. BRADLOW, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol. 78:123-129, 2000.
4. BENTZ, A. T., C. M. SCHNEIDER, and K. C. WESTERLIND. The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone and the 2/16 ratio in premenopausal women. Cancer Causes Control 16:455-461, 2004.
5. BRADLOW, H. L., D. L. DAVIS, G. LIN, D. SEPKOVIC, and R. TIWARI. Effects of pesticides on the ratio of 16α-/2-hydroxyestrone: a biological marker of breast cancer risk. Environ. Health Perspect. 103(Suppl 7):147-150, 1995.
6. BRADLOW, H. L., R. J. HERSHCOPF, C. P. MARTUCCI, and J. FISHMAN. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. 82:6295-6299, 1985.
7. BRADLOW, H. L., N. T. TELANG, D. W. SEPKOVIC, and M. P. OSBORNE. 2-hydroxyestrone: the "good" estrogen. J. Endocrinol. 150:5259-5265, 1996.
8. BULLEN, B. A., G. S. SKRINAR, I. Z. BEITUNG, G. VON MERING, B. A. TURNBULL, and J. W. MCARTHUR. Induction of menstrual disorders by strenuous exercise in untrained women. N. Engl. J. Med. 312:1349-1353, 1985.
9. CAMPBELL, K. L., K. C. WESTERLIND, V. J. HARBER, C. M. FRIEDENREICH, and K. S. COURNEYA. Association between aerobic fitness and estrogen metabolites in premenopausal women. Med. Sci. Sports Exerc. 37:585-592, 2005.
10. CAULEY, J. A., J. M. ZMUDA, M. E. DANIELSON, et al. Estrogen metabolites and the risk of breast cancer in older women. Epidemiol. 14:635-640, 2003.
11. DALESSANDRI, K. M., G. L. FIRESTONE, M. D. FITCH, H. L. BRADLOW, and L. F. BJELDANES. Pilot study: effect of 3.3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr. Cancer 50:161-167, 2004.
12. DECREE, C., P. BALL, B. SEIDLITZ, G. VAN KRANENBURG, P. GEURTEN, and H. A. KEIZER. Effects of a training program on resting plasma 2-hydroxycatecholestrogen levels in eumenorrheic women. J. Appl. Physiol. 83:1551-1556, 1997.
13. DESOUZA, M. J., and N. I. WILLIAMS. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum. Reprod. Update 10:433-438, 2004.
14. ELIASSEN, A. H., S. A. MISSMER, S. S. TWOROGER, and S. E. HANKINSON. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J. Clin. Oncol. 24:1823-1830, 2006.
15. FISHMAN, J., and C. MARTUCCI. Biological properties of 16α-hydroxyestrone: implications in estrogen physiology and pathophysiology. J. Clin. Endocrinol. Metab. 51:611-615, 1980.
16. FOWKE, J. H., C. LONGCOPE, and J. R. HERBERT. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9:773-779, 2000.
17. FRIEDENRECH, C. M., K. S. COURNEYA, and H. E. BRYANT. Relation between intensity of physical activity and breast cancer risk reduction. Med. Sci. Sports Exercise 33:1538-1545, 2001.
18. FRIEDENREICH, C. M., and M. R. ORENSTEIN. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J. Nutr. 132:3456S-3464S, 2002.
19. GAMMON, M. D., E. M. JOHN, and J. A. BRITTON. Recreational and occupational physical activities and risk of breast cancer. J. Natl. Cancer Inst. 90:100-117, 1998.
20. GARNER, D. M., and M. P. OLMSTEAD. Manual for Eating Disorder Inventory. Odessa, FL: Psychological Assessment Resources, Inc., 1984.
21. HARRIS, J. A., and F. G. BENEDICT. A Biometric Study of the Basal Metabolism in Man. Washington, DC: Carnegie Institution of Washington, DC, 1919. Publication no. 279.
22. KABAT, G. C., C. J. CHANG, J. A. SPARANO, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 6:505-509, 1997.
23. KABAT, G. C., E. S. O'LEARY, M. D. GAMMON, et al. Estrogen metabolism and breast cancer. Epidemiology 17:80-88, 2006.
24. LEE-JANE, W. L., M. CREE, S. JOSYULA, M. NAGAMANI, J. J. GRADY, and K. E. ANDERSON. Increased urinary excretion of 2-hydroxyestrone but not 16α-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res. 60:1299-1305, 2000.
25. LOUCKS, A. B., and J. R. THUMA. Lutenizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J. Clin. Endocrinol. Metab. 88:297-311, 2003.
26. MEILAHN, E. N., B. DE STAVOLA, D. S. ALLEN, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort followup. Br. J. Cancer 78:1250-1255, 1998.
27. MUTI, P., H. L. BRADLOW, A. MICHELI, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone rat in premenopausal and postmenopausal women. Epidemiology 11:635-640, 2000.
28. PASAGIAN-MACAULAY, A., E. N. MEILAHN, H. L. BRADLOW, et al. Urinary markers of estrogen metabolism 2- and 16α-hydroxylation in premenopausal women. Steroids 61:461-467, 1996.
29. PIKE, M. C., D. V. SPENCER, L. DAHMOUSH, and M. F. PRESS. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15:17-35, 1993.
30. REED, G. A., K. S. PETERSON, H. J. SMITH, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol. Biomarkers Prev. 14:1953-1960, 2005.
31. RUSSELL, J. B., D. MITCHELL, P. I. MUSEY, and D. C. COLLINS. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet. Gynecol. 63: 452-456, 1984.
32. SCHNEIDER, J., M. M. HUH, H. L. BRADLOW, and J. FISHMAN. Antiestrogen activation of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem. 259:4840-4845, 1984.
33. SNOW, R. C., R. L. BARBIERI, and R. E. FRISCH. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J. Clin. Endocrinol. Metab. 69:369-376, 1989.
34. SWANECK, G. E., and J. FISHMAN. Covalent binding of the endogenous estrogen 16>-hydoxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. 85:7831-7835, 1988.
35. TELANG, N. T., D. M. AVELROD, G. Y. WONG, H. L. BRADLOW, and M. P. OSBORNE. Biotransformation of estradiol by explant culture of human mammary tissue. Steroids 56:37-43, 1991.
36. URSIN, G., S. LONDON, F. Z. STANCZYK, et al. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 91:1067-1072, 1999.
37. WESTERLIND, K. C., K. J. GIBSON, P. MALONE, G. L. EVANS, and R. T. TURNER. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J. Bone Miner. Res. 13:1023-1031, 1998.
38. WESTERLIND, K. C., K. J. GIBSON, and P. WOLFE. The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment. Steroids 64:233-243, 1999.
39. XU, X., A. M. DUNCAN, K. E. WANGEN, and M. S. KURZER. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9: 781-786, 2000.
40. ZHENG, W., L. DUNNING, F. JIN, and J. HOLTZMAN. Correspondence re: G. C. Kabat et al, Urinary estrogen metabolites and breast cancer: a case control study. Cancer Epidemiol. Biomarkers Prev. 78:85-86, 1998.
41. ZHU, B. T., and A. H. CONNEY. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27, 1998.